FDA to hold public meeting on chronic pain therapy

FDA will hold a public meeting July 9 to discuss drug development for chronic pain. Topics include the symptoms and daily affect of chronic pain on patients and patients' perspectives on current treatment.

FDA Commissioner Scott Gottlieb said in a blog post the meeting will allow patients to express their views on chronic pain treatment and challenges to accessing therapy. ...